Respiratory bronchiolar-associated interstitial lung disease
Interstitial lung disease (ILD) is a general term for clinical-pathological entities that are composed of different types of disease groups with diffuse lung parenchyma, alveolar inflammation and interstitial fibrosis as basic pathological lesions, and clinical manifestations such as active dyspnea, diffuse infiltration shadows on chest X-rays, restrictive ventilation disorders, reduced diffusion (DLCO) function and hypoxemia. Respiratory bronchiolar-associated interstitial lung disease is a different clinical syndrome that occurs in recent or former smokers.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
All -
Related symptoms:
Fatigue shortness of breath respiratory failure chest pain dry cough -
Concurrent disease:
Related Drugs
Sulbactam Sodium for Injection
Indication: This product is used in combination with penicillins or cephalosporins to treat urinary tract infections, lung infections, bronchial infections, ENT infections, abdominal and pelvic infections, biliary tract infections, sepsis, skin and soft tissue infections, etc. caused by sensitive bacteria.
Manufacturer:
Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
Ceftiofiorin Hydrochloride for Injection
Indication: Used to treat infections caused by sensitive bacteria, such as pneumonia, bronchitis, bile tract infection, peritonitis, urinary tract infection, as well as infections and sepsis caused by surgery and trauma.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Related Ingredients